Camlin Fine Sciences Ltd
Camlin Fine Sciences Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #11 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
3 of 3 strong
The short version
Vanillin demand expected to pick up with an estimated 3,000 to 4,000 tons for the year, though production may be limited due to ongoing campaigns (Page 17). EBITDA expected to improve by at least 6% if raw material and margin pressures normalize (Page 18).
From Camlin Fine Sciences Ltd's Q1 FY27 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- Vanillin demand expected to pick up with an estimated 3,000 to 4,000 tons for the year, though production may be limited due to ongoing campaigns (Page 17).
- Peak vanillin plant utilization aimed at 5,000 tons per year with up to 3 campaigns annually (Page 17).
- Revenue guidance targets INR2,200 to INR2,300 crores for the full year with EBITDA margins of 10-11% (Page 6).
- Blends growing at a 20% CAGR, showing strong growth momentum (Page 13).
2 more points from Camlin Fine Sciences Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Camlin Fine Sciences Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is working on alternatives for the diphenol plant, considering new phenolic compounds as potential products. A decision regarding the plant's future use or restart is expected by the third quarter. (Page 6)
- There is a focus on scaling up vanillin production campaigns, with plans to ideally run up to 3 campaigns a year and reach production capacity of around 5,000 tons, indicating potential capacity investments or utilization of existing capacity. (Page 17)
- Management is evaluating ways to "sweat" the existing Performance Chemicals plant assets to achieve better margins and returns; options are being finalized in the coming months. (Page 15)
2 more points from Camlin Fine Sciences Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Camlin Fine Sciences Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Camlin Fine Sciences Ltd's call on order book
Create a free account to keep reading this call
Camlin Fine Sciences Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹425 Cr, net profit ₹86 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Camlin Fine's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Camlin Fine Sciences Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Camlin Fine Sciences Ltd Q1 FY27 results?
Vanillin demand expected to pick up with an estimated 3,000 to 4,000 tons for the year, though production may be limited due to ongoing campaigns (Page 17). EBITDA expected to improve by at least 6% if raw material and margin pressures normalize (Page 18).
What is Camlin Fine Sciences Ltd share price analysis?
Camlin Fine Sciences Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of N/A with a market cap of ₹1,993 Cr. Investors should review the full earnings analysis for detailed insights.
Is Camlin Fine Sciences Ltd planning capital expenditure?
The company is working on alternatives for the diphenol plant, considering new phenolic compounds as potential products.
Keep Camlin Fine Sciences Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.